A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

Clinical trial NCT06685068 · TERMINATED

Trial details

NCT number: NCT06685068
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-11-13
Primary completion: 2026-03-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.